ATE33649T1 - Gegen magengeschwuer wirkende 2-guanidino-4-(2substituierte-amino-4-imidazolyl)thiazole und verfahren zu deren herstellung. - Google Patents

Gegen magengeschwuer wirkende 2-guanidino-4-(2substituierte-amino-4-imidazolyl)thiazole und verfahren zu deren herstellung.

Info

Publication number
ATE33649T1
ATE33649T1 AT83302495T AT83302495T ATE33649T1 AT E33649 T1 ATE33649 T1 AT E33649T1 AT 83302495 T AT83302495 T AT 83302495T AT 83302495 T AT83302495 T AT 83302495T AT E33649 T1 ATE33649 T1 AT E33649T1
Authority
AT
Austria
Prior art keywords
guanidino
imidazolyl
amino
preparation
thiazole
Prior art date
Application number
AT83302495T
Other languages
English (en)
Inventor
John Lawrence Lamattina
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE33649T1 publication Critical patent/ATE33649T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT83302495T 1982-05-10 1983-05-04 Gegen magengeschwuer wirkende 2-guanidino-4-(2substituierte-amino-4-imidazolyl)thiazole und verfahren zu deren herstellung. ATE33649T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/376,486 US4435396A (en) 1982-05-10 1982-05-10 Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
EP83302495A EP0094191B1 (de) 1982-05-10 1983-05-04 Gegen Magengeschwür wirkende 2-Guanidino-4-(2-substituierte-amino-4-imidazolyl)thiazole und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
ATE33649T1 true ATE33649T1 (de) 1988-05-15

Family

ID=23485203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83302495T ATE33649T1 (de) 1982-05-10 1983-05-04 Gegen magengeschwuer wirkende 2-guanidino-4-(2substituierte-amino-4-imidazolyl)thiazole und verfahren zu deren herstellung.

Country Status (26)

Country Link
US (1) US4435396A (de)
EP (1) EP0094191B1 (de)
JP (1) JPS58206588A (de)
KR (1) KR860000931B1 (de)
AT (1) ATE33649T1 (de)
AU (2) AU539244B2 (de)
CA (1) CA1201120A (de)
CS (1) CS252461B2 (de)
DD (1) DD209828A5 (de)
DE (1) DE3376322D1 (de)
DK (1) DK163829B (de)
EG (1) EG17029A (de)
ES (1) ES522223A0 (de)
FI (1) FI78481C (de)
GR (1) GR79279B (de)
GT (1) GT198302123A (de)
HU (2) HU190899B (de)
IE (1) IE55229B1 (de)
IL (1) IL68630A (de)
NO (1) NO159932C (de)
NZ (1) NZ204158A (de)
PL (1) PL141199B1 (de)
PT (1) PT76662B (de)
SU (1) SU1195907A3 (de)
YU (1) YU42857B (de)
ZA (1) ZA833286B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
WO1986003203A1 (en) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Thienylthiazole derivatives
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
ES2031514T3 (es) * 1986-08-29 1992-12-16 Pfizer Inc. 2-guanidino-4-ariltiazoles para el tratamiento de ulceras pepticas.
DE3750023T2 (de) * 1986-10-29 1994-09-29 Pfizer Verfahren zur Herstellung von 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)Thiazol und dessen kristallinisches Dihydrochlorid-Trihydrat.
CA2165344A1 (en) * 1993-06-15 1994-12-22 Peter C. Canning Immune stimulants in bacterial infections
KR101406433B1 (ko) 2008-09-22 2014-06-13 카이맨 케미칼 컴파니 인코포레이티드 Ｈ-ｐｇｄｓ 억제제로서 다중헤테로아릴 화합물 및 프로스타글란딘 ｄ2 매개된 질병의 치료를 위한 그의 용도
EP4196793A1 (de) 2020-08-11 2023-06-21 Université de Strasbourg Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519637A (en) 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
DE2142585A1 (de) * 1971-08-20 1973-02-22 Schering Ag 2-(5-nitro-2-thiazolyl)-benzimidazole
FR2284601A1 (fr) * 1974-09-10 1976-04-09 Inst Francais Du Petrole Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants
US4220654A (en) 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4374843A (en) 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
FI831595A0 (fi) 1983-05-09
ES8407045A1 (es) 1984-08-16
IE55229B1 (en) 1990-07-04
GT198302123A (es) 1984-10-27
US4435396A (en) 1984-03-06
PT76662B (en) 1986-04-16
FI78481C (fi) 1989-08-10
SU1195907A3 (ru) 1985-11-30
DK205883D0 (da) 1983-05-09
PL141199B1 (en) 1987-07-31
CS252461B2 (en) 1987-09-17
KR840004745A (ko) 1984-10-24
NZ204158A (en) 1986-05-09
EG17029A (en) 1992-06-30
YU42857B (en) 1988-12-31
DD209828A5 (de) 1984-05-23
AU3081584A (en) 1984-11-08
EP0094191B1 (de) 1988-04-20
YU99683A (en) 1986-02-28
KR860000931B1 (ko) 1986-07-19
IE831061L (en) 1983-11-10
EP0094191A1 (de) 1983-11-16
IL68630A (en) 1987-03-31
HU190899B (en) 1986-12-28
GR79279B (de) 1984-10-22
CS318483A2 (en) 1987-02-12
ES522223A0 (es) 1984-08-16
DK205883A (da) 1983-11-11
FI831595L (fi) 1983-11-11
AU539244B2 (en) 1984-09-20
FI78481B (fi) 1989-04-28
AU566755B2 (en) 1987-10-29
PT76662A (en) 1983-06-01
AU1436383A (en) 1983-11-17
NO159932C (no) 1989-02-22
JPS58206588A (ja) 1983-12-01
ZA833286B (en) 1984-12-24
NO159932B (no) 1988-11-14
PL241840A1 (en) 1985-01-16
DE3376322D1 (en) 1988-05-26
IL68630A0 (en) 1983-09-30
HU196377B (en) 1988-11-28
NO831632L (no) 1983-11-11
DK163829B (da) 1992-04-06
CA1201120A (en) 1986-02-25

Similar Documents

Publication Publication Date Title
AU4127189A (en) Benzimidazole derivatives, process for preparing the same and antiulcer agents containing the same
DE3586822T2 (de) Halbleiteranordnung und verfahren zu deren herstellung.
IT8223561A0 (it) Metodo per l'eliminazione dirifiuti organici.
DE3381711D1 (de) Halbleiteranordnung und verfahren zu deren herstellung.
DE3763912D1 (de) Schwimmfaehiger fuellstoff, verfahren zu dessen herstellung und diesen stoff enthaltende rohrkonstruktionen.
DE3280128D1 (de) Modifiziertes vaccinia virus und verfahren zu dessen herstellung und verwendung.
DE3750899T2 (de) Polymer für Toner, dessen Herstellungsverfahren und Tonerzusammensetzung.
DE3579419D1 (de) Einstufiges hydrobehandlungsverfahren.
DE3782201D1 (de) Halbleiterphotosensor und verfahren zu dessen herstellung.
DE3578262D1 (de) Elektrode eines halbleiterbauelements und verfahren zu ihrer herstellung.
ATE33649T1 (de) Gegen magengeschwuer wirkende 2-guanidino-4-(2substituierte-amino-4-imidazolyl)thiazole und verfahren zu deren herstellung.
DE3879536T3 (de) Supraleitender keramischer Film und Verfahren zu dessen Herstellung.
ES515538A0 (es) "mejoras introducidas en el metodo de efectuar una reaccion de fermentacion".
DE3764026D1 (de) Verfahren zum aufbereiten von gebrauchten primaerzellen.
AT384614B (de) Verfahren zum herstellen von neuen thiazolo (3,2-a)pyrimidinen
BA97167B1 (bs) Postupak za pripravu 7,16-dioksa-2 aza-10-0-kladinozil-12-0 desozaminil-4,5-dihidroksi-6-etil 3,5,9,11,13,15-heksametilbiciklo (11.2.1)heksadeka-1 (2)-en-8-ona
OA06491A (fr) Procédé pour la restauration d'une couche aquifère.
DE69207575T2 (de) Verfahren zum Herstellen von 2,3-Dichlor-1-propanol und dafür verwendeter Reaktor
IT8223703A0 (it) Procedimento di trattamento di micelio, in particolare derivato da processi di fermentazione dell'industria chimico-farmaceutica, per smaltimento ecologico.
ATE42222T1 (de) Adsorbent und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee